Cited by 103Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

The potential of predictive analytics to provide clinical decision support in depression treatment planning

Kessler, Ronald C.·2018·Current Opinion in Psychiatry

DOI 10.1097/yco.0000000000000377

Open this paper in CoChat — free account

Abstract

PURPOSE OF REVIEW: To review progress developing clinical decision support tools for personalized treatment of major depressive disorder (MDD). RECENT FINDINGS: Over the years, a variety of individual indicators ranging from biomarkers to clinical observations and self-report scales have been used to predict various aspects of differential MDD treatment response. Most of this work focused on predicting remission either with antidepressant medications versus psychotherapy, some antidepressant medications versus others, some psychotherapies versus others, and combination therapies versus monotherapies. However, to date, none of the individual predictors in these studies has been strong enough to guide optimal treatment selection for most patients. Interest consequently turned to decision support tools made up of multiple predictors, but the development of such tools has been hampered by small study sample sizes. Design recommendations are made here for future studies to address this problem. SUMMARY: Recommendations include using large prospective observational studies followed by pragmatic trials rather than smaller, expensive controlled treatment trials for preliminary development of decision support tools; basing these tools on comprehensive batteries of inexpensive self-report and clinical predictors (e.g., self-administered performance-based neurocognitive tests) versus expensive biomarkers; and reserving biomarker assessments for targeted studies of patients not well classified by inexpensive predictor batteries.

Integrity signals

Registry

Crossref · 10.1097/yco.0000000000000377

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Approximately 30% of MDD patients remit after a full first course of evidencebased treatment and 70% remit after several courses of treatment [4].”
Background
Cross-national epidemiology of DSM-IV major depressive episode
Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., de Girolamo, G., de Graaf, R., Demyttenaere, K., Hu, C., Iwata, N., et al. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-90 · Cited by 2,221
Self-citation
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Drysdale, A. T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., Fetcho, R. N., Zebley, B., Oathes, D. J., Etkin, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4246 · Cited by 2,170
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Undertreatment of people with major depressive disorder in 21 countries
Thornicroft, G., Chatterji, S., Evans-Lacko, S., Gruber, M., Sampson, N., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Andrade, L., Borges, G., et al. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.188078 · Cited by 1,121
Self-citation
Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis
Andersson, G., Cuijpers, P., Carlbring, P., Riper, H., & Hedman, E. (2014) · World Psychiatry · doi:10.1002/wps.20151 · Cited by 1,077 · cited 1×
“A number of classes of ADMs exist, but none has consistently been found superior to all others, resulting in ADM treatment recommendations being differential effects [10–12].”
Result
Distributed Disturbances in Brain Structure and Function in Schizophrenia
Lewis, D. A. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 971
The Costs of Depression
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Self-citation
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma
Nemeroff, C. B., Heim, C. M., Thase, M. E., Klein, D. N., Rush, A. J., Schatzberg, A. F., Ninan, P. T., McCullough, J. P., Weiss, P. M., Dunner, D. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336126100 · Cited by 829
Estimating Individualized Treatment Rules Using Outcome Weighted Learning
Zhao, Y., Zeng, D., Rush, A. J., & Kosorok, M. R. (2012) · Journal of the American Statistical Association · doi:10.1080/01621459.2012.695674 · Cited by 746
Inflammation and clinical response to treatment in depression: A meta-analysis
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.007 · Cited by 666
Comparative Efficacy of Seven Psychotherapeutic Interventions for Patients with Depression: A Network Meta-Analysis
Barth, J., Munder, T., Gerger, H., Nüesch, E., Trelle, S., Znoj, H., Jüni, P., & Cuijpers, P. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001454 · Cited by 569
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
Parikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
McGrath, C. L., Kelley, M. E., Holtzheimer, P. E., Dunlop, B. W., Craighead, W. E., Franco, A. R., Craddock, R. C., & Mayberg, H. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.143 · Cited by 561
The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta‐analysis of direct comparisons
Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2013) · World Psychiatry · doi:10.1002/wps.20038 · Cited by 540
Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.
(2000) · PubMed · Cited by 509
Experiments with More Than One Random Factor: Designs, Analytic Models, and Statistical Power
Judd, C. M., Westfall, J., & Kenny, D. A. (2017) · Annual Review of Psychology · doi:10.1146/annurev-psych-122414-033702 · Cited by 466
Correcting for Optimistic Prediction in Small Data Sets
Smith, G. C. S., Seaman, S. R., Wood, A., Royston, P. J., & White, I. R. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu140 · Cited by 357
Systematic review of prognostic models in traumatic brain injury
Perel, P., Edwards, P. J., Wentz, R., & Roberts, I. (2006) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-6-38 · Cited by 351
Data-driven subtypes of major depressive disorder: a systematic review
van Loo, H. M., de Jonge, P., Romeijn, J., Kessler, R. C., & Schoevers, R. A. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-156 · Cited by 339
Self-citation
Meta-review of depressive subtyping models
Harald, B., & Gordon, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.015 · Cited by 328 · cited 1×
“…(e.g., atypical or melancholic depression), or empirically derived symptom profiles in hopes of predicting heterogeneity of treat-ment effects (HTE), where HTE is defined as the existence of between-patient differences in the relative effectiveness of different types of treat-ment [24,25].”
Background
Measurement-based care versus standard care for major depression: A randomized controlled trial with blind raters
Guo, T., Xiang, Y.-T., Xiao, L., Hu, C.-Q., Chiu, H. F. K., Ungvari, G. S., Correll, C. U., Lai, K. Y. C., Feng, L., Geng, Y., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14050652 · Cited by 308
Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials
Lipkovich, I., Dmitrienko, A., & B., R. (2017) · Statistics in Medicine · doi:10.1002/sim.7064 · Cited by 291
A systematic review of comparative efficacy of treatments and controls for depression
Khan, A., Faucett, J., Lichtenberg, P., Kirsch, I., & Brown, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041778 · Cited by 288
Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design
Trivedi, M. H., McGrath, P. J., Fava, M., Parsey, R. V., Kurian, B. T., Phillips, M. L., Oquendo, M. A., Bruder, G., Pizzagalli, D., Toups, M., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.03.001 · Cited by 286
Increasing the acceptance of internet-based mental health interventions in primary care patients with depressive symptoms. A randomized controlled trial
Ebert, D. D., Berking, M., Cuijpers, P., Lehr, D., Pörtner, M., & Baumeister, H. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.056 · Cited by 268 · cited 1×
“Research has also shown that patient preferences for treatment type can be influenced by informational interventions [59].”
Background
Identifying Predictors, Moderators, and Mediators of Antidepressant Response in Major Depressive Disorder: Neuroimaging Approaches
Phillips, M. L., Chase, H. W., Sheline, Y. I., Etkin, A., Almeida, J. R. C., Deckersbach, T., & Trivedi, M. H. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010076 · Cited by 267
Untitled work
(2012) · Re-Unir (International University of La Rioja) · Cited by 262
Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies
GENDEP Investigators, MARS Investigators, STAR*D Investigators, Uher, R., Tansey, K. E., Henigsberg, N., Wolfgang, M. C., Mors, O. N., Hauser, J., Placentino, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020237 · Cited by 250
Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review
Carlo, V. D., Calati, R., & Serretti, A. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.034 · Cited by 219
Predicting Optimal Outcomes in Cognitive Therapy or Interpersonal Psychotherapy for Depressed Individuals Using the Personalized Advantage Index Approach
Huibers, M. J. H., Cohen, Z. D., Lemmens, L. H. J. M., Arntz, A., Peeters, F. P. M. L., Cuijpers, P., & DeRubeis, R. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140771 · Cited by 215
Primary Care Patients’ Involvement in Decision-Making Is Associated With Improvement in Depression
Clever, S. L., Ford, D. E., Rubenstein, L. V., ROST, K. M., Meredith, L. S., Sherbourne, C. D., Wang, N., Arbelaez, J. J., & Cooper, L. A. (2006) · Medical Care · doi:10.1097/01.mlr.0000208117.15531.da · Cited by 210
Vagal nerve stimulation for treatment-resistant depression
Carreno, F. R., & Frazer, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0537-8 · Cited by 208
Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder
Kessler, R. C., van Loo, H. M., Wardenaar, K. J., Bossarte, R. M., Brenner, L. A., Ebert, D. D., de Jonge, P., Nierenberg, A. A., Rosellini, A. J., Sampson, N. A., et al. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000020 · Cited by 193
Self-citation
The influence of patient preference on depression treatment in primary care
Lin, P., Campbell, D. G., Chaney, E. F., Liu, C.-F., Heagerty, P., Felker, B. L., & Hedrick, S. C. (2005) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm3002_9 · Cited by 192
Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects
Karyotaki, E., Smit, Y., Holdt Henningsen, K., Huibers, M. J. H., Robays, J., de Beurs, D., & Cuijpers, P. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.01.036 · Cited by 189
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression
Uher, R., Maier, W., Hauser, J., Marušič†, A., Schmael, C., Mors, O. N., Henigsberg, N., Souery, D., Placentino, A., Rietschel, M., et al. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.057554 · Cited by 186
Estimating treatment effects for individual patients based on the results of randomised clinical trials
Dorresteijn, J. A. N., Visseren, F. L. J., Ridker, P. M., Wassink, A. M. J., Paynter, N. P., Steyerberg, E. W., van der Graaf, Y., & Cook, N. R. (2011) · BMJ · doi:10.1136/bmj.d5888 · Cited by 177
European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe
Jobst, A., Brakemeier, E., Buchheim, A., Caspar, F., Cuijpers, P. J., Ebmeier, K. P., Falkai, P., van der Gaag, R. J., Gäebel, W., Herpertz, S. C., et al. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2015.12.003 · Cited by 176
Self-guided internet-based and mobile-based stress management for employees: results of a randomised controlled trial
Ebert, D. D., Heber, E., Berking, M., Riper, H., Cuijpers, P., Funk, B., & Lehr, D. (2016) · Occupational and Environmental Medicine · doi:10.1136/oemed-2015-103269 · Cited by 176
PERSONALIZED TREATMENT OF ADULT DEPRESSION: MEDICATION, PSYCHOTHERAPY, OR BOTH? A SYSTEMATIC REVIEW
Cuijpers, P. J., Reynolds, C. F., Donker, T., Li, J., Andersson, G., & Beekman, A. T. F. (2012) · Depression and Anxiety · doi:10.1002/da.21985 · Cited by 175
Effectiveness of psychological interventions in preventing recurrence of depressive disorder: Meta-analysis and meta-regression
Biesheuvel-Leliefeld, K. E. M., Kok, G. D., Bockting, C. L. H., Cuijpers, P., Hollon, S. D., van Marwijk, H. W. J., & Smit, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.016 · Cited by 175
Personalized Medicine: Review and Perspectives of Promising Baseline EEG Biomarkers in Major Depressive Disorder and Attention Deficit Hyperactivity Disorder
Olbrich, S., van Dinteren, R., & Arns, M. (2015) · Neuropsychobiology · doi:10.1159/000437435 · Cited by 154
Does Internet-based guided-self-help for depression cause harm? An individual participant data meta-analysis on deterioration rates and its moderators in randomized controlled trials
Ebert, D. D., Donkin, L., Andersson, G., Andrews, G., Berger, T., Carlbring, P., Rozenthal, A., Choi, I., Laferton, J. A. C., Johansson, R., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291716001562 · Cited by 154
Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study
Dunlop, B. W., Kelley, M. E., Aponte‐Rivera, V., Mletzko, T., Kinkead, B. L., Ritchie, J., Nemeroff, C. B., Craighead, W. E., Mayberg, H. S., & for the PReDICT Team (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050517 · Cited by 148
Economic evaluations of internet- and mobile-based interventions for the treatment and prevention of depression: A systematic review
Paganini, S., Teigelkötter, W., Buntrock, C., & Baumeister, H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.07.018 · Cited by 144
Evidence-Based Recommendations for the Prescription of Exercise for Major Depressive Disorder
Rethorst, C. D., & Trivedi, M. H. (2013) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000430504.16952.3e · Cited by 141
Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
Hashimoto, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047796 · Cited by 141
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
Biernacka, J. M., Sangkuhl, K., Jenkins, G., Whaley, R. M., Barman, P., Batzler, A., Altman, R. B., Arolt, V, Brockmöller, J., Chen, C. H., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.47 · Cited by 140
Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder?: A Systematic Review of Clinical Trials and Cost-Effectiveness Studies
Rosenblat, J. D., Lee, Y., & McIntyre, R. S. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15r10583 · Cited by 138
Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression
Njau, S. N., Joshi, S. H., Espinoza, R. T., Leaver, A. M., Vasavada, M. M., Marquina, A., Woods, R. P., & Narr, K. L. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150177 · Cited by 134
Combination Psychotherapy and Antidepressant Medication Treatment for Depression: For Whom, When, and How
Craighead, W. E., & Dunlop, B. W. (2011) · Annual Review of Psychology · doi:10.1146/annurev.psych.121208.131653 · Cited by 130
Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder.
Harkness, K. L., Bagby, R. M., & Kennedy, S. H. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0027665 · Cited by 116
Divergent outcomes in cognitive-behavioral therapy and pharmacotherapy for adult depression
Vittengl, J. R., Jarrett, R. B., Weitz, E., Hollon, S. D., Twisk, J., Cristea, I., David, D., DeRubeis, R. J., Dimidjian, S., Dunlop, B. W., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040492 · Cited by 97 · cited 1×
“However,MDDHTErandomized controlledtreatmenttrialsareuniformlysmall controlledtreatmenttrialsareuniformlysmall(typically n ¼ 200–800) [65–67,68 & ,69].”
A prognostic index (PI) as a moderator of outcomes in the treatment of depression: A proof of concept combining multiple variables to inform risk-stratified stepped care models
Lorenzo‐Luaces, L., DeRubeis, R. J., van Straten, A., & Tiemens, B. G. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.010 · Cited by 96
Psychotherapy Versus Second-Generation Antidepressants in the Treatment of Depression
Spielmans, G. I., Berman, M. I., & Usitalo, A. N. (2011) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31820caefb · Cited by 95
Drop out from out-patient mental healthcare in the World Health Organization's World Menta Health Survey initiative
Wells, J. E., Browne, M. A. O., Aguilar‐Gaxiola, S., Al-Hamzawi, A., Alonso, J., Angermeyer, M. C., Bouzan, C., Bruffaerts, R., Bunting, B., Caldas‐de‐Almeida, J. M., et al. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.113134 · Cited by 92
Self-citation
Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis
Papadimitropoulou, K., Vossen, C., Karabis, A., Donatti, C., & Kubitz, N. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1277201 · Cited by 91
Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response
Fabbri, C., Hosák, L., Mößner, R., Giegling, I., Mandelli, L., Bellivier, F., Claes, S. J., Collier, D. A., Corrales, A., DeLisi, L. E., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1208843 · Cited by 84
Efficacy and cost-effectiveness of minimal guided and unguided internet-based mobile supported stress-management in employees with occupational stress: a three-armed randomised controlled trial
Ebert, D. D., Lehr, D., Smit, F., Zarski, A.-C., Riper, H., Heber, E., Cuijpers, P., & Berking, M. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-807 · Cited by 82
Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine
Nassan, M. M., Nicholson, W. T., Elliott, M. A., Vitek, C. R. R., Black, J. L., & Frye, M. A. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.02.023 · Cited by 79
Executive dysfunction and treatment response in late‐life depression
Pimontel, M. A., Culang‐Reinlieb, M. E., Morimoto, S. S., & Sneed, J. R. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2808 · Cited by 76
Investigational drugs in recent clinical trials for treatment-resistant depression
Garay, R. P., Zarate, C. A., Charpeaud, T., Citrome, L., Correll, C. U., Hameg, A., & Llorca, P. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1283217 · Cited by 76
Abnormal functional connectivity within resting-state networks is related to rTMS-based therapy effects of treatment resistant depression: A pilot study
Ge, R., Blumberger, D. M., Downar, J. H., Daskalakis, Z. J., Dipinto, A. A., Tham, J. C. W., Lam, R. W. M., & Vila‐Rodriguez, F. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.060 · Cited by 75
Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
Bousman, C., Forbes, M., Jayaram, M., Eyre, H. A., Reynolds, C. F., Berk, M., Hopwood, M., & Ng, C. H. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1230-5 · Cited by 72
Effectiveness of a Web-Based Guided Self-help Intervention for Outpatients With a Depressive Disorder: Short-term Results From a Randomized Controlled Trial
Kenter, R., Cuijpers, P., Beekman, A., & van Straten, A. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.4861 · Cited by 66
Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: A systematic review and meta-analysis
von Wolff, A., Hölzel, L. P., Westphal, A., Härter, M. C., & Kriston, L. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-61 · Cited by 64
Optimal Individualized Treatments in Resource-Limited Settings
Luedtke, A. R., & van der Laan, M. J. (2016) · The International Journal of Biostatistics · doi:10.1515/ijb-2015-0007 · Cited by 64
Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies
Thase, M. E. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/mthase · Cited by 57
EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline
Arns, M., Gordon, E., & Boutros, N. N. (2015) · Clinical EEG and Neuroscience · doi:10.1177/1550059415621435 · Cited by 51
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED Trial Report
Sung, S. C., Wisniewski, S. R., Balasubramani, G. K., Zisook, S., Kurian, B. T., Warden, D., Trivedi, M. H., & Rush, A. J. (2012) · Psychological Medicine · doi:10.1017/s0033291712001742 · Cited by 49
Measuring the Cost of Quality Measurement
Schuster, M. A., Onorato, S. E., & Meltzer, D. (2017) · JAMA · doi:10.1001/jama.2017.11525 · Cited by 46
Digital Technology and Clinical Decision-Making in Depression Treatment: Current Findings and Future Opportunities
Hallgren, K. A., Bauer, A. M., & Atkins, D. C. (2017) · Depression and Anxiety · doi:10.1002/da.22640 · Cited by 45
Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression
Cuijpers, P. J., Weitz, E. S., Lamers, F., Penninx, B. W. J. H., Twisk, J. W. R., DeRubeis, R. J., Dimidjian, S., Dunlop, B. W., Jarrett, R. B., Segal, Z. V., et al. (2016) · Depression and Anxiety · doi:10.1002/da.22580 · Cited by 41
Recent advances in predicting responses to antidepressant treatment
Frodl, T. (2017) · F1000Research · doi:10.12688/f1000research.10300.1 · Cited by 40
Blood-based immune-endocrine biomarkers of treatment response in depression
Chan, M. K., Cooper, J. D., Bot, M., Birkenhäger, T. K., Bergink, V., Drexhage, H. A., Steiner, J. H., Rothermundt, M., Penninx, B. W. J. H., & Bahn, S. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.08.020 · Cited by 36
Psychotherapy Versus Pharmacotherapy of Depression: What’s the Evidence?
Leichsenring, F., Steinert, C., & Hoyer, J. (2016) · Zeitschrift für psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2016.62.2.190 · Cited by 33
Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial
Gadad, B. S., Jha, M. K., Grannemann, B. D., Mayes, T. L., & Trivedi, M. H. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.05.012 · Cited by 30
Evaluating the impact of treating the optimal subgroup
Luedtke, A. R., & van der Laan, M. J. (2017) · Statistical Methods in Medical Research · doi:10.1177/0962280217708664 · Cited by 29
Time to remission from mild to moderate depressive symptoms: One year results from the EVIDENT-study, an RCT of an internet intervention for depression
Klein, J. P., Späth, C., Schröder, J., Meyer, B., Greiner, W., Hautzinger, M., Lutz, W., Rose, M., Vettorazzi, E., Andersson, G., et al. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.07.013 · Cited by 25
Statistical analysis plan for stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) study
Petkova, E., Ogden, R. T., Tarpey, T., Ciarleglio, A., Jiang, B., Su, Z., Carmody, T. J., Adams, P., KRAEMER, H. C., Grannemann, B. D., et al. (2017) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2017.02.007 · Cited by 24
Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
Jha, M. K., Teer, R., Minhajuddin, A., Greer, T. L., Rush, A. J., & Trivedi, M. H. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s128407 · Cited by 23
Veterans with depression in primary care: Provider preferences, matching, and care satisfaction.
Waltz, T. J., Campbell, D. G., Kirchner, J. E., Lombardero, A., Bolkan, C. R., Zivin, K., Lanto, A. B., Chaney, E. F., & Rubenstein, L. V. (2014) · Families Systems & Health · doi:10.1037/fsh0000071 · Cited by 19
The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: A secondary analysis
Bausch, P., Fangmeier, T., Zobel, I., Schoepf, D., Drost, S., Schnell, K., Walter, H., Berger, T., Normann, C., & Schramm, E. (2017) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2081 · Cited by 19
Toward an online cognitive and emotional battery to predict treatment remission in depression
Rekshan, W. R., Gordon, E., Palmer, D., Braund, T. A., & Rush, A. J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75975 · Cited by 16
The science of risk models
Prieto‐Merino, D., & Pocock, S. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312448995 · Cited by 11
The role of APOE-ɛ4 and beta amyloid in the differential rate of recovery from ECT: a review
Sutton, T. A., Sohrabi, H. R., Rainey‐Smith, S. R., Bird, S. M., Weinborn, M., & Martins, R. N. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.39 · Cited by 7

Sorted by citations

WHO World Mental Health Surveys International College Student Project: Prevalence and distribution of mental disorders.
Auerbach, R. P., Collaborators, W. W.-I., Mortier, P., Bruffaerts, R., Alonso, J., Benjet, C., Cuijpers, P., Demyttenaere, K., Ebert, D. D., Green, J. G., et al. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000362 · Cited by 2,522
Self-citation
Time for united action on depression: a Lancet–World Psychiatric Association Commission
Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02141-3 · Cited by 1,104
Self-citation
Treatment selection in depression.
Cohen, Z. D., & DeRubeis, R. J. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084746 · Cited by 435
The clinical characterization of the adult patient with depression aimed at personalization of management
Maj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., Demyttenaere, K., McIntyre, R. S., Widiger, T., & Wittchen, H. (2020) · World Psychiatry · doi:10.1002/wps.20771 · Cited by 435
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Li, Z., Ruan, M., Chen, J., & Fang, Y. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00638-3 · Cited by 372

See all 103

Authors: Kessler, R. C.
Affiliations: Harvard University (US)
Corresponding author: Kessler, Ronald C.
ORCID: Kessler, Ronald C.
Venue: Current Opinion in Psychiatry
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2018-01
Volume: 31
Issue: 1
Pages: 32-39
ISSN: 0951-7367 (ISSN-L)
DOI: 10.1097/yco.0000000000000377
OpenAlex: W2765870488
Cited by: 103
References: 88
Citations by year: 2026: 4 · 2025: 10 · 2024: 9 · 2023: 14 · 2022: 17 · 2021: 14 · 2020: 11 · 2019: 18 · 2018: 6
FWCI: 1.22
Type: journal article
Language: en
Open access: closed
Locations: Current Opinion in Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords: predictive analytics, clinical decision support, major depressive disorder, personalized treatment, treatment response prediction, antidepressants, psychotherapy, combination therapy, remission prediction, biomarkers, self-report scale, neurocognitive tests, pragmatic trials
MeSH terms: Antidepressive Agents, Combined Modality Therapy, Major Depressive Disorder, Humans, Prospective Studies, Psychotherapy, Decision Support Systems, Clinical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The potential of predictive analytics to provide clinical decision support in depression treatment planning

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks